Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Becerra, Carlos R.
1305  Ergebnisse:
Personensuche X
?
1

Author Correction: Targeting LIF-mediated paracrine interac..:

Shi, Yu ; Gao, Weina ; Lytle, Nikki K....
Nature.  600 (2021)  7889 - p. E18-E18 , 2021
Link: https://doi.org/10.1038/..
 
?
2

A phase I, open-label study evaluating the safety and pharm..:

Saif, Muhammad Wasif ; Becerra, Carlos R. ; Fakih, Marwan G....
Cancer Chemotherapy and Pharmacology.  88 (2021)  3 - p. 485-497 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patie..:

Hong, David S. ; Kang, Yoon-Koo ; Borad, Mitesh...
British Journal of Cancer.  122 (2020)  11 - p. 1630-1637 , 2020
Link: https://doi.org/10.1038/..
 
?
4

Targeting LIF-mediated paracrine interaction for pancreatic..:

Shi, Yu ; Gao, Weina ; Lytle, Nikki K....
Nature.  569 (2019)  7754 - p. 131-135 , 2019
Link: https://doi.org/10.1038/..
 
?
5

A Phase 1, Open-Label, Randomized, Crossover Study Evaluati..:

Becerra, Carlos R. ; Yoshida, Kenichiro ; Mizuguchi, Hirokazu..
The Journal of Clinical Pharmacology.  57 (2017)  6 - p. 751-759 , 2017
Link: https://doi.org/10.1002/..
 
?
6

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors:

Gelhorn, Heather L. ; Tong, Sandra ; McQuarrie, Kelly...
Clinical Therapeutics.  38 (2016)  4 - p. 778-793 , 2016
Link: https://doi.org/10.1016/..
 
?
7

An innovative, multi-arm, complete phase 1b study of the no..:

Jotte, Robert M. ; Von Hoff, Daniel D. ; Braiteh, Fadi...
Investigational New Drugs.  33 (2014)  1 - p. 148-158 , 2014
Link: https://doi.org/10.1007/..
 
?
8

A phase I dose-escalation study of MEDI-575, a PDGFRα monoc..:

Becerra, Carlos R. ; Conkling, Paul ; Vogelzang, Nicholas...
Cancer Chemotherapy and Pharmacology.  74 (2014)  5 - p. 917-925 , 2014
Link: https://doi.org/10.1007/..
 
?
9

Phase I study of the MEK inhibitor trametinib in combinatio..:

Tolcher, Anthony W. ; Patnaik, Amita ; Papadopoulos, Kyriakos P....
Cancer Chemotherapy and Pharmacology.  75 (2014)  1 - p. 183-189 , 2014
Link: https://doi.org/10.1007/..
 
?
10

Figitumumab in patients with refractory metastatic colorect..:

Becerra, Carlos R. ; Salazar, Ramon ; Garcia-Carbonero, Rocio...
Cancer Chemotherapy and Pharmacology.  73 (2014)  4 - p. 695-702 , 2014
Link: https://doi.org/10.1007/..
 
?
11

Phase 2 trial of afatinib, an ErbB family blocker, in solid..:

Kwak, Eunice L. ; Shapiro, Geoffrey I. ; Cohen, Seth M....
Cancer.  119 (2013)  16 - p. 3043-3051 , 2013
Link: https://doi.org/10.1002/..
 
?
12

Adverse Effects of Bevacizumab and Their Management in Soli..:

Arriaga, Yull ; Becerra, Carlos R.
Supportive Cancer Therapy.  3 (2006)  4 - p. 247-250 , 2006
Link: https://doi.org/10.3816/..
 
?
13

A phase II clinical and pharmacokinetic study of intravenou..:

Ajani, Jaffer A. ; Takimoto, Chris ; Becerra, Carlos R....
Investigational New Drugs.  23 (2005)  5 - p. 479-484 , 2005
Link: https://doi.org/10.1007/..
 
?
14

IκB Kinase α Regulates Subcellular Distribution and Turnove..:

Kwak, Youn-Tae ; Li, Rui ; Becerra, Carlos R....
Journal of Biological Chemistry.  280 (2005)  40 - p. 33945-33952 , 2005
Link: https://doi.org/10.1074/..
 
?
15

IκB kinase α regulates subcellular distribution and turnove..:

Kwak, Youn-Tae ; Li, Rui ; Becerra, Carlos R....
Journal of Biological Chemistry.  280 (2005)  46 - p. 38888 , 2005
Link: https://doi.org/10.1016/..
 
1-15